ArticleCancer immunology, immunotherapy : CII2025

Efficacy and safety of local-regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.

Shuofeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.